Operational sustainability is severely compromised by a dwindling cash position of only $65,900 as of 2026Q1, forcing a reliance on external financing to cover ongoing cash burn.
| Cash from Operations | -3.11M | -3.87M | -2.84M | -6.64M | -23.76M | -15.05M | -481.43K |
| Operating CF Margin % | - | -23.61% | -70.11% | -4573.58% | -4649.71% | -12545.83% | -764.17% |
| Operating CF Growth % | 144.08% | -36.07% | 57.25% | 72.03% | -57.82% | -3027.17% | - |
| Net Income | -13.27M | -12.45M | -12.42M | -26.45M | -95.25M | -38.49M | -1.78M |
| Depreciation & Amortization | 188.89K | 597.43K | 1.24M | 1.28M | 1.51M | 98K | 0 |
| Stock-Based Compensation | -257.4K | -164.21K | -101.73K | 381K | 11.04M | 131K | 0 |
| Deferred Taxes | -182.83K | -182.83K | 0 | 0 | 0 | 400K | 0 |
| Other Non-Cash Items | 10.23M | 8.1M | 5.67M | 10.13M | 62.3M | 22.23M | 1.75M |
| Working Capital Changes | -300.72K | 229.45K | 2.78M | 8.02M | -3.35M | 572K | -443.18K |
| Change in Receivables | 1.84M | 0 | 553.93K | 18.57M | 890K | -1.92M | 0 |
| Change in Inventory | 3.03K | 0 | 40.27K | 1.31M | -1.02M | -295K | 0 |
| Change in Payables | -372.1K | 0 | 1.16M | 1.3M | 127K | 3.09M | 0 |
| Cash from Investing | -659.6K | -655.61K | 13.33K | 0 | -1.87M | -355K | -201.25M |
| Capital Expenditures | -80.92K | -62.02K | 0 | 0 | -110K | -242K | 0 |
| CapEx % of Revenue | 0.44% | 0.38% | - | - | 21.53% | 201.67% | 0.01% |
| Acquisitions | -493.58K | 0 | 13.33K | 0 | 0 | -63K | 0 |
| Investments | - | - | - | - | - | - | - |
| Other Investing | -85.1K | -593.59K | 0 | 0 | -1.76M | -50K | 0 |
| Cash from Financing | 3.81M | 4.66M | 2.86M | 1.17M | 24.29M | 14.14M | 203.2M |
| Debt Issued (Net) | -332.04K | 1.56M | 2.81M | 291K | 30.3M | 10.5M | -141.13K |
| Equity Issued (Net) | 0 | 3.1M | 89.92K | 1.18M | 0 | 0 | 203.29M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 4.15M | 0 | -42K | -299K | -6.01M | 3.64M | 50K |
| Net Change in Cash | 48.99K | 139.19K | 30.15K | -5.48M | -1.34M | -1.27M | 1.42M |
| Free Cash Flow | -2.47M | -3.93M | -2.84M | -6.64M | -25.63M | -15.3M | -481.42K |
| FCF Margin % | -13.46% | -23.99% | -70.11% | -4573.58% | -5015.66% | -12747.5% | -764.16% |
| FCF Growth % | 34.45% | -38.25% | 57.25% | 74.07% | -67.55% | -3077.47% | - |
| FCF per Share | -0.00 | -0.01 | -0.19 | -1.58 | -22.60 | -26.28 | -2.41 |
| FCF Conversion (FCF/Net Income) | 0.19x | 0.31x | 0.23x | 0.25x | 0.25x | 0.39x | 0.06x |
| Interest Paid | 0 | 0 | 0 | 0 | 1.22M | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Imminent liquidity crisis
As reported in recent financial statements, FOXO's operating cash flow frequently diverges from net income, with OCF/NI ratios swinging from 0.01 to 4.56, suggesting that reported earnings are heavily influenced by non-cash items and accruals rather than actual cash generation from core epigenetic testing operations.
The extreme volatility in the OCF/NI ratio indicates that the company's accounting earnings provide little insight into its underlying cash-generating capacity. Investors should monitor whether this disconnect stems from aggressive revenue recognition or timing mismatches in service delivery, as the lack of consistent cash conversion complicates any valuation based on traditional earnings multiples.
Based on the provided quarterly data, FOXO's free cash flow trajectory remains erratic, oscillating between a positive $661.1K in 2025Q4 and a negative $2.4M in 2025Q2, which highlights the company's inability to establish a predictable or sustainable path toward positive cash flow generation.
The lack of a stable FCF trend suggests that the business model is currently reliant on sporadic inflows rather than recurring operational success. This instability, combined with the negative FCF margins observed in most periods, implies that the company remains in a cash-burning phase that necessitates constant external funding.
According to historical cash flow data, working capital changes have been a primary driver of cash flow variability, with swings as large as $2.3M in 2023Q4, suggesting that the company's cash position is highly sensitive to the timing of collections and payables management.
The significant fluctuations in working capital indicate that FOXO may be struggling to manage its cash conversion cycle effectively. Such volatility often suggests that the company is either pulling forward revenue or delaying payments to manage its precarious liquidity position, which warrants further investigation into the quality of its accounts receivable.
As indicated by the provided cash flow statements, FOXO has limited capacity for capital deployment, with historical dividends and acquisitions appearing as isolated events that contrast sharply with the company's ongoing operational cash burn and the urgent need to preserve its dwindling cash reserves.
The absence of consistent capital deployment strategies reflects a firm focused entirely on survival rather than growth-oriented investment. Given the current cash balance of approximately $207,000, any future capital allocation will likely be directed toward covering operating deficits rather than strategic initiatives, further limiting the company's long-term competitive potential.
Quick answers to the most common questions about buying FOXO stock.
FOXO Technologies Inc. (FOXO) generated $-3.9M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
FOXO Technologies Inc. (FOXO) reported negative free cash flow of $3.9M in 2025, indicating capital requirements exceeded cash from operations.
FOXO Technologies Inc. (FOXO) spent $0.1M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.